On November 1, 2023, the Chinese Society of Medical Equipment announced our NET632 Dual-Head Variable-Angle SPECT as a top domestic device, recognizing our excellence in SPECT technology.
Our NET632:The NET632, independently developed by Novel Medical, received approval through the national innovative medical device special review. This device fills gaps in domestic technology, effectively replacing imported products and supporting national strategic goals.
Performance and Adoption: Meeting internationally advanced technical standards, the NET632 has been adopted by top domestic hospitals. It has garnered widespread praise for its superior image quality, flexible functionality, and excellent user experience.
Our Vision: Novel Medical remains committed to our core values of integrity, responsibility, perseverance, and ownership. We continue to prioritize innovation, providing comprehensive nuclear medicine solutions. Our goal is to enhance wellbeing through advancements in nuclear medicine and contribute to its rapid development in China.
Language
